US Stock MarketDetailed Quotes

GOSS Gossamer Bio

Watchlist

1.030
+0.070+7.31%

Close Jul 3 13:00 ET

1.000
-0.030-2.91%

Post 16:23 ET

233.01MMarket Cap-1211P/E (TTM)

Gossamer Bio Stock Forum

Mafiosa818

Jun 25 13:51

$Gossamer Bio(GOSS.US)$ 👀

Jaguar8

Jun 24 17:49

Added NEWS

$Gossamer Bio(GOSS.US)$
Gossamer Bio a new outperform at Oppenheimer on seralutinib for PAH
• Oppenheimer has initiated Gossamer Bio at outperform expressing optimism on seralutinib, its inhaled tyrosine kinase inhibitor for pulmonary arterial hypertension (PAH).
• The firm has a $9 price target (~984% upside based on June 24 close).
• Analyst Andreas Argyrides said that the candidate's safety and efficacy profile makes it "a preferred choice among severe PAH patients who are not ad...

Trytosaveabit

Jun 24 17:39

Insider buy

$Gossamer Bio(GOSS.US)$ Officer Hasnain Faheem purchased 372K shares of common stock on Jun 21, 2024 at an average price of $0.6728 for a total value of $250.28K.

Marioboss

May 7 19:51

$Gossamer Bio(GOSS.US)$ Hold tight one dollar soon

Trytosaveabit

May 7 15:06

Decent capital!

$Gossamer Bio(GOSS.US)$ Gossamer Bio Inc: $396 Mln in Cash, Cash Equivalents & Marketable Securities, as of March 31, 2024! Enough to fund operations into Q1 2027

Trytosaveabit

May 6 13:50

Hmm?

$Gossamer Bio(GOSS.US)$ Really thought that this part of the deal ((( Chiesi will pay Gossamer $160 million as a development reimbursement. Additionally, Gossamer will be eligible to receive up to $146 million in regulatory milestones and $180 million in sales milestones. ))) Potentially 486M, woulda garnered a bit more attention? Well i like it and will continue adding on dips for now! Hehehe! NFA

Daight

May 6 13:04

$Gossamer Bio(GOSS.US)$ climb climb baby climb!

Trytosaveabit

May 6 06:44

Update

$Gossamer Bio(GOSS.US)$ Gossamer Bio and Chiesi Group Announce Transformative Global Collaboration to Develop and Commercialize Seralutinib in Pah, Ph-Ild & Other Indications
Gossamer Bio Inc: Eligible to Receive up to $146 Mln in Regulatory and $180 Mln in Sales Milestones

Trytosaveabit

May 3 07:06

Encouraging

$Gossamer Bio(GOSS.US)$ Benzinga· 2 mins ago
Gossamer Bio Published TORREY Phase 2 Results In Lancet Respiratory Medicine

Trytosaveabit

Mar 4 15:07

Update

$Gossamer Bio(GOSS.US)$ On March 4, 2024, Gossamer Bio Received Letter Stating That It Has Regained Compliance With Minimum Bid Price Requirement For Continued Listing On Nasdaq
Moomoo 24/7· just

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall